John Simard
44Patents
11h-index
5Co-inventors
68Inventor score
Filing activity: Apr 28, 2000 → Jun 21, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8034337B2 | Interleukin-1α antibodies | Physics | 1,007 | Active |
| US6861234B1 | Method of epitope discovery | Emerging Cross-Sectional Technologies | 44 | Expired |
| US8252916B2 | Expression vectors encoding epitopes of target-associated antigens and methods for their design | Physics | 43 | Expired |
| US6977074B2 | Method of inducing a CTL response | Chemistry; Metallurgy | 42 | Expired |
| US7364729B2 | Method of inducing a CTL response | Chemistry; Metallurgy | 19 | Expired |
| US7232682B2 | Expression vectors encoding epitopes of target-associated antigens and methods for their design | Physics | 19 | Expired |
| US8388956B2 | Interleukin-1 alpha antibodies and methods of use | Physics | 13 | Active |
| US8388969B2 | Interleukin-1 alpha antibodies and methods of use | Physics | 13 | Active |
| US9486523B2 | Compositions and methods for treating and preventing Staphylococcus aureus infections | Chemistry; Metallurgy | 13 | Active |
| US8242074B2 | Modulation of the amount or function of pathogenic CD14+CD16+ monocytes | Human Necessities | 12 | Active |
| US9416172B2 | Compositions and methods for treating and preventing Staphylococcus aureus infections | Chemistry; Metallurgy | 12 | Active |
| US8784817B2 | Method for killing IL-1 alpha expressing cells | Physics | 7 | Active |
| US9840558B2 | Human antibody specific for interleukin-1alpha | Physics | 7 | Active |
| US8679489B2 | Inhibiting cell migration | Physics | 7 | Active |
| US8372393B2 | Method of inducing a CTL response | Chemistry; Metallurgy | 7 | Active |
| US8546331B2 | Modulation of pathogenic CD14+/CD16+ monocytes | Human Necessities | 6 | Active |
| US10202449B2 | Cachexia treatment | Chemistry; Metallurgy | 5 | Active |
| US7252824B2 | Anti-neovasculature preparations for cancer | Human Necessities | 5 | Expired |
| US9783598B2 | Compositions and methods for treating and preventing Staphylococcus aureus infections | Chemistry; Metallurgy | 4 | Active |
| US8637305B2 | Expression vectors encoding epitopes of target-associated antigens and methods for their design | Physics | 4 | Expired |
| US9809649B2 | Cachexia treatment | Chemistry; Metallurgy | 3 | Active |
| US10899833B2 | Human antibody specific for interleukin-1 alpha | Physics | 3 | Active |
| US9181338B2 | Human antibody specific for IL-1alpha | Physics | 3 | Active |
| US10294296B2 | Treatment for neoplastic diseases | Chemistry; Metallurgy | 3 | Active |
| US10214581B2 | Compositions and methods for treating and preventing Staphylococcus aureus infections | Chemistry; Metallurgy | 3 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.